Literature DB >> 3818603

Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium.

D A Jencks, R G Mathews.   

Abstract

In this paper we report on the allosteric regulation of the dimeric flavoprotein methylenetetrahydrofolate reductase (E.C. 1.5.1.20) by the inhibitor, AdoMet, and by one of the substrates, NADPH. These metabolites play antagonistic roles in this regulation, with NADPH recruiting active forms of the enzyme and AdoMet recruiting inactive forms. At high NADPH concentrations, activity dependence on AdoMet is sigmoidal, indicating cooperativity. The kinetics of inhibition induced by AdoMet are slow enough to be studied by conventional methods and exhibit marked biphasicity. Both the extents and rates of these phases are again affected antagonistically by the ligands, AdoMet increasing the extent of the faster phase, and NADPH decreasing the extent of the faster phase and the rate of the slower phase. We present a model consistent with these observations. Our model postulates two states of the enzyme, R and T. NADPH and AdoMet exhibit antagonistic binding to a given subunit, so that occupancy by one ligand decreases or abolishes affinity for the other ligand. However, within a given state, the subunits do not interact with each other, so the ligation of one does not affect the affinities of its neighbor. R-T transitions occur between all similarly ligated states. The ligands have different affinities for the R and T states, and AdoMet binding to a given subunit is measurably slow. This model predicts the observed features of the equilibrium and kinetic data noted above. We also present a system for simulation of reaction schemes in which each step is pseudo first order that is fast and versatile enough to allow least squares fitting of microscopic rate constants to kinetic data.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3818603

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia.

Authors:  J L Wiemels; R N Smith; G M Taylor; O B Eden; F E Alexander; M F Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Low-Dose Creatine Supplementation Lowers Plasma Guanidinoacetate, but Not Plasma Homocysteine, in a Double-Blind, Randomized, Placebo-Controlled Trial.

Authors:  Brandilyn A Peters; Megan N Hall; Xinhua Liu; Faruque Parvez; Abu B Siddique; Hasan Shahriar; Mohammad Nasir Uddin; Tariqul Islam; Vesna Ilievski; Joseph H Graziano; Mary V Gamble
Journal:  J Nutr       Date:  2015-08-26       Impact factor: 4.798

Review 3.  The epigenetics of adult (somatic) stem cells.

Authors:  Kenneth J Eilertsen; Z Floyd; Jeffrey M Gimble
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

Review 4.  Disorders of homocysteine metabolism.

Authors:  B Fowler
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

5.  Ethnogeographic prevalence and implications of the 677C>T and 1298A>C MTHFR polymorphisms in US primary care populations.

Authors:  James S Graydon; Karla Claudio; Seth Baker; Mohan Kocherla; Mark Ferreira; Abiel Roche-Lima; Jovaniel Rodríguez-Maldonado; Jorge Duconge; Gualberto Ruaño
Journal:  Biomark Med       Date:  2019-06-03       Impact factor: 2.851

Review 6.  Homocysteine imbalance: a pathological metabolic marker.

Authors:  Kevin L Schalinske; Anne L Smazal
Journal:  Adv Nutr       Date:  2012-11-01       Impact factor: 8.701

7.  Gene expression profiles of the one-carbon metabolism pathway.

Authors:  Yin Leng Lee; Xinran Xu; Sylvan Wallenstein; Jia Chen
Journal:  J Genet Genomics       Date:  2009-05       Impact factor: 4.275

Review 8.  Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview.

Authors:  Anna E Beaudin; Patrick J Stover
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

9.  Persistent hypermethioninaemia with dominant inheritance.

Authors:  H J Blom; A J Davidson; J D Finkelstein; A S Luder; I Bernardini; J J Martin; A Tangerman; J M Trijbels; S H Mudd; S I Goodman
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

10.  Modulation of phosphatidylcholine biosynthesis by peroxisome proliferating fatty acid analogues.

Authors:  J Skorve; A M Svardal; M A Mansoor; R K Berge
Journal:  Lipids       Date:  1993-09       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.